Explore more
Trump unveils ‘AI action plan’ for US dominance in AI race
Digest more
Insiders tell CNN the FDA’s AI is “hallucinating” studies and can’t access key documents. Agency leaders insist the AI is getting better, and use is not mandatory.
Artificial intelligence (AI) promises to be one of the most transformative technologies in human history, and certain Wall Street analysts think Palantir Technologies ( PLTR 0.15%) and AppLovin ( APP -0.50%) are particularly well positioned to benefit.
From streamlining clinical trials to identifying new drug candidates in record time, artificial intelligence is transforming the pharmaceutical industry. Coming up tonight, News Channel 3 will beak down how this technology works,
NVIDIA CEO and co-founder Jensen Huang commends President Donald Trump’s A.I. agenda and outlines what the country's job future will look like on 'Special Report.'
AI is dumbing us down. But paradoxically, when used judiciously in combination with human thought, the very same tool could be a doorway to increased wisdom.
An AI hallucination occurs when a model confidently produces an incorrect output — a faulty conclusion based on inaccurate or misinterpreted data patterns. The machine doesn’t “know” it’s wrong. It simply detects a pattern, extrapolates from it and moves on, often without signaling that its reasoning may be flawed.
Artificial intelligence (AI) investing remains the prevailing market theme, and it doesn't appear to be slowing. Even though 2025 is halfway over, there are still plenty of AI stocks that are worth your investment dollars and could see impressive growth throughout the rest of the year.
As one of the first Clerk of Court offices in Louisiana to adopt AI for indexing public records, the team is embracing this technology to enhance efficiency and accuracy.
Feedback